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Effect of Qigong on hypertension: a randomised controlled study
BMY Cheung, JLF Lo, SK Chan,1 MY Chan,1 DY Fong,2 RKW Leung,1 S Wong,1 V Wong,3 KSL Lam, CP Lau, PWH Lee,4
JPE Karlberg.2 Department of Medicine, Department of Psychiatry4 & Clinical Trials Centre,2 University of Hong Kong;
Queen Mary Hospital;1 Hospital Authority, Hong Kong3
Introduction: The cause of essential hypertension remains unknown in most patients. Exercise and relaxation
therapy are useful in decreasing blood pressure. We conducted a randomised controlled trial to examine the effects
of Guolin qigong on blood pressure, other cardiovascular risk factors and psychosocial well-being in patients with
mild essential hypertension.
Method: After informed consent, each patient was randomised to practice either qigong or conventional exercise
daily for 16 weeks. In addition to clinical and laboratory assessments, SF-36, Beck Anxiety Inventory and Beck
Depression Inventory version II questionnaires were also completed by the patients.
Results: Ninety-one patients were recruited but 3 patients withdrew before the intervention period. Qigong skills
were harder to master than conventional exercise. Sodium level increased by 1.18±0.46 mmol/l more in the qigong
group at week 16 (p=0.012). Heart rate was higher by 3.2±1.3 bpm in the qigong group at week 4 (p=0.016) but not
subsequently. Ambulatory daytime systolic BP as well as night-time systolic and diastolic BP were higher by
4.89±2.11 mmHg (p=0.024), 6.19±2.45 mmHg (p=0.014) and 5.54±1.53 mmHg (p=0.001) respectively in the
qigong group at week 16. Systolic and diastolic blood pressure, calcium, cholesterol, renin, weight, BMI, waist,
hip, and urine protein significantly decreased in both groups at week 16. General health, mental health, social
functioning, anxiety, and depression also improved in both groups. One female in the qigong group developed
vestibular neuronitis.
Conclusions: Both Guolin qigong and conventional exercise lower blood pressure in patients with mild essential
hypertension. It may therefore be an alternative to conventional exercise as part of the non-pharmacological man-
agement of hypertension.
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Effects of 293B, a selective IKs blocker, on transient outward and ultra-rapid
delayed rectifier K+ currents in human atrial myocytes
XL Du, CP Lau, SW Chiu, HF Tse, GR Li. ICSM/Department of Medicine, Faculty of Medicine, The University of Hong Kong
Introduction: Previous reports demonstrated that chromanol 293B, a so-called selective blocker of slow com-
ponent of delayed rectifier K+ current (IKs), inhibited other channel currents. It is unclear whether 293B may affect
other K+ currents in human atrium.
Methods: With whole-cell patch clamp technique, we studied effects of 293B on transient outward K+ current (Ito1)
and ultra-rapid delayed rectifier K+ current (IKur) in isolated human atrial myocytes. Experiments were conducted at
room temperature.
Results: It was found that 293B reversibly inhibited Ito1 and IKur in a concentration-dependent manner, and the
effect was not dependent on depolarizing voltage. Concentration for 50% inhibition (IC50) was 31.2 µM for
Ito1, and 30.9 µM for IKur. 293B blocked Ito1 and IKur with same concentration range, and significant effect was
observed from a concentration of 1 µM, and reached maximum effect at 250 µM. Voltage-dependent kinetics
of activation and inactivation, and time-dependent recovery from inactivation of Ito1 were not altered by
293B; however, time to peak and time-dependent inactivation of Ito1 was significantly accelerated.
Conclusion: The results indicate that the so-called IKs blocker 293B significantly inhibits major repolarization K+
currents, Ito1 and IKur, in human atrial myocytes.
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